老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ultragenyx Pharmaceutical Inc

35.69
+0.71002.03%
盤後：35.63-0.0600-0.17%16:31 EDT
成交量：69.08萬
成交額：2,454.04萬
市值：33.51億
市盈率：-5.68
高：35.74
開：35.00
低：34.74
收：34.98
資料載入中...
總覽公司新聞公告
2021/04/16

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/12

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

重要事件披露

8-K - Current report
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/21

重要事件披露

8-K - Current report
2021/01/11

重要事件披露

8-K - Current report
2021/01/08

重要事件披露

8-K - Current report
2020/12/17

重要事件披露

8-K - Current report
2020/12/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/07

重要事件披露

8-K - Current report
2020/11/06

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/11/02

重要事件披露

8-K - Current report
2020/10/27

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
更多